CTIS2024-512731-74-00进行中（未招募）1 期
Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICTORIA)
illebaelt Hospital0 个研究点目标入组 70 人开始时间: 2024年3月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Male or female, age 18 years or older, •Female patients must agree to practice highly effective method of birth control until at least 30 days after the last dose of study treatment. Highly effective method of birth control is defined as the combination of both a hormonal and a barrier method of contraception, •Ability to understand the purpose and risks of the study and provide signed and dated informed consent;, •Adequate organ function with the following laboratory results: oAbsolute neutrophil count = 1,000 cells/mm3 (1.0 x 109/L) oPlatelet count = 30,000 cells/ mm3 (30 x 109/L) (without transfusions required within 10 days prior to initiation of study treatment) oHemoglobin = 5 mmol/l; red blood cell transfusions and treatment with erythropoietin are permitted oTotal Bilirubin = 1.5 x upper limit of normal, except patients diagnosed with Gilbert’s syndrome that have been approved by the sponsor oAlanine transaminase = 3.0 x upper limit of normal oRenal function: Estimated creatinine clearance by Cockcroft- Gault formula of = 30 mL/min, •A prior diagnosis of multiple myeloma, •At least one prior line of therapy, •The presence of t(11;14) by fluorescent in situ hybridization, •Relapsed or refractory disease defined as oprogressive disease ?during treatment with the last line of therapy or ?within 60 days after the last line of therapy or ominimal response or better not achieved after completion of at least two cycles of the last line of therapy, •Measurable disease defined as any of the following: oSerum monoclonal protein = 10 g/L by serum protein electrophoresis o = 200 mg of monoclonal protein in the urine on 24-hour electrophoresis oSerum free light chain = 100 mg/L and abnormal serum kappa to lambda free light chain (FLC) ratio, •Life expectancy of = 6 months, •ECOG performance status = 2. (Patients with performance status > 2 based solely on bone pain secondary to multiple myeloma may be eligible following approval of the sponsor);, •A negative serum or urine pregnancy test if the subject is a female of childbearing potential, defined as any sexually mature female who: ohas not undergone a hysterectomy or bilateral oophorectomy and ohas not been naturally postmenopausal for at least 24 consecutive months ?A sexually mature female who stopped having menstrual cycles due to cancer therapy cannot be considered naturally postmenopausal
排除标准
- •Any somatic or psychiatric condition that in the investigator’s opinion would impose excessive risk to the patient or would adversely affect the patient’s participation in this study, •Cardiovascular disability status of New York Heart Association Class greater than or equal to 3, •Severe ongoing infection that in the investigator’s opinion would impose excessive risk to the patient, •Known intolerance to the study treatment, •Pregnant or breast-feeding females, •Known human immunodeficiency virus or active hepatitis B or C viral infection, •The use of live vaccines within 30 days before initiation of study treatment, •Autologous stem cell transplant within 12 weeks prior to initiation of study treatment, •Prior allogeneic stem cell transplantation with active graft-versus-host-disease, •= Grade 3 cardiac conduction system abnormalities unless patient has a pacemaker
研究者
相似试验
进行中（未招募）
1 期
Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICTORIA)Multiple MyelomaEUCTR2020-001102-29-DKDepartment of Internal Medicine Vejle Hospital70
招募中
1 期
Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLHHemophagocytic LymphohistiocytosisNCT05546060Beijing Friendship Hospital20
招募中
2 期
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple MyelomaRelapsed and Refractory Multiple MyelomaNCT05530421University of Miami33
尚未招募
不适用
Effect of combined use of two drugs dexamethasone and dexmedetomidine on duration of nerve blockCTRI/2020/11/029153SRI manakula vinayagar medical college hospital RESEARCH FUND
已完成
不适用
To compare the pain relief during labour using a epidural local anaesthetic and an opioid versus epidural local anaesthetic and opioid along with intravenous steroid(dexamethasone)CTRI/2014/05/004596GMCH chandigarh80